Taysha Gene Therapies
TSHA
#5788
Rank
C$1.76 B
Marketcap
C$5.40
Share price
-5.51%
Change (1 day)
-4.12%
Change (1 year)

Taysha Gene Therapies (TSHA) - Total debt

Total debt on the balance sheet as of June 2026 : C$81.21 Million

According to Taysha Gene Therapies's latest financial reports the company's total debt is C$81.21 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Taysha Gene Therapies - Total debt on balance sheet (from 2020 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$96.05 M5.95%
2024-12-31C$90.66 M11.86%
2023-12-31C$81.04 M-0.33%
2022-12-31C$81.31 M1.13%
2021-12-31C$80.4 M
2020-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
C$4.76 M-94.14%๐Ÿ‡บ๐Ÿ‡ธ USA